本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Terns Pharmaceuticals, Inc.

2.40
+0.16007.14%
盤後2.450.0450+1.87%16:56 EDT
成交量:89.17萬
成交額:211.83萬
市值:2.10億
市盈率:-2.15
高:2.44
開:2.23
低:2.23
收:2.24
資料載入中...
2025/03/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/20

重要事件披露

Form 8-K - Current report
2025/02/24

重要事件披露

Form 8-K - Current report
2025/02/20

重要事件披露

Form 8-K - Current report
2025/02/06

重要事件披露

Form 8-K - Current report
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/06

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]